spesolimab
Drug Details
- Generic Name
- spesolimab
- Brand Names
- SPEVIGO
- Application Number
- BLA761244
- Sponsor
- LEO Pharma Inc.
- NDC Codes
- 4
- Dosage Forms
- INJECTION, LIQUID
- Routes
- SUBCUTANEOUS
- Active Ingredients
- SPESOLIMAB
Indications and Usage
1 INDICATIONS AND USAGE SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg. SPEVIGO is an interleukin-36 receptor antagonist indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg. ( 1 )